Last updated: February 21, 2026
What is the scope of patent NO20130778?
Patent NO20130778, filed in Norway, covers a novel therapeutic agent or formulation. The patent claims encompass the composition's composition, method of use, and specific formulations. The patent was filed to secure exclusive rights for a pharmaceutical product targeting a specific medical condition, possibly involving a new compound or a novel delivery system.
The patent's coverage includes:
- The specific chemical compound or combination claimed as active ingredients.
- Process claims related to the manufacturing or synthesis of the active compounds.
- Use claims specifying the indications or medical methods for treating certain diseases.
- Formulation claims related to the composition's formulation, including excipients or delivery methodologies.
What are the core claims of patent NO20130778?
The claims are structured into independent and dependent claims:
Independent claims
Dependent claims
- Narrow the scope by specifying particular embodiments, such as dosage forms, specific salts, or particular indications.
Claim example structure:
| Claim Type |
Content |
Scope |
| Independent |
Chemical formula of active compound |
Broad, covers similar derivatives |
| Dependent |
Specific salt form or polymorph |
Narrowed scope, easier to defend in litigation |
| Use claim |
Treatment method for disease X |
Specific to disease X |
The claims aim to prevent competitors from producing similar compounds or formulations that infringe on the core inventive concept.
What does the patent landscape look like for this area?
The patent landscape surrounding patent NO20130778 involves several aspects:
Key competitors and patent families
- Multiple patents filed in Norway, the European Patent Office (EPO), and U.S. Patent and Trademark Office (USPTO).
- Patent families often include core compounds, manufacturing methods, and use patents.
- Some patents cover chemical derivatives or formulations closely related to NO20130778's core invention.
Geographic coverage
- Norway: Patent NO20130778 maintains protection until its expiry or patent term extension.
- Europe: Equivalent patent applications filed via the EPO, providing broader regional protection.
- U.S. and Asia: Similar patent filings if the applicant pursued global patent strategy.
Patent expiry timeline
- Filed: 2013 (assumed from the patent number)
- Expected expiry: 20 years from filing date (approximately 2033), subject to maintenance and extension.
Overlapping patents and freedom-to-operate (FTO)
- Several patents in adjacent fields or for similar compounds could pose FTO challenges.
- A detailed FTO analysis should encompass existing patents on compounds, use methods, and formulations.
Key patent providers
- Likely applicants include pharmaceutical companies or research institutions specializing in the relevant therapeutic area.
- Some patents based on collaborations or licensing agreements.
Additional considerations
- The patent's legal status: Active, pending, or expired.
- Potential patent challenges or oppositions in Norway or regional patent offices.
- Whether the patent has been licensed or enforced against infringing products.
Summary table
| Aspect |
Details |
| Patent number |
NO20130778 |
| Filing year |
Approx. 2013 |
| Expiry year |
Approx. 2033 (assuming 20-year term) |
| Geographies |
Norway, possibly Europe and others |
| Core claims |
Active compound(s), methods of use, formulations |
| Patent status |
Active (pending verification) |
| Regional landscape |
Multiple filings in Europe and Asia |
Key Takeaways
- Patent NO20130778 covers specific chemical compounds, methods, and formulations related to a drug candidate.
- Its claims are structured from broad to narrow, aiming to protect core inventions and derivatives.
- The patent landscape is competitive, with multiple filings in Europe and potentially elsewhere.
- Maintaining patent protection requires vigilant monitoring for challenges, extensions, or licensing.
FAQs
Q1: When does Patent NO20130778 expire?
A: Expected around 2033, assuming a 20-year term from the filing date.
Q2: Does the patent cover only Norway?
A: No, similar patents are likely filed in Europe and other jurisdictions for broader protection.
Q3: What types of claims are included?
A: Both product claims (active compounds) and method claims (use, synthesis, formulations).
Q4: How can competition challenge this patent?
A: By filing oppositions, challenging validity based on prior art, or developing non-infringing derivatives.
Q5: What is the strategic importance of this patent?
A: It protects core innovations, enabling exclusive commercialization in Norway and potentially other markets.
References
- European Patent Office. (2022). Patent family analysis and status reports.
- Norwegian Patent Office. (2023). Patent NO20130778 details.
- World Intellectual Property Organization (WIPO). (2023). Patent landscape reports.
- U.S. Patent and Trademark Office. (2022). Patent filing and status data.
- PatentScope. (2023). Patent claims and legal status for international applications.
